Improving the lives of those with
hearing loss through the study of genetics
We study genetic hearing loss from bench to bedside using a combination of big data and clinical knowledge to advance the field.
Our mission is to translate discoveries from the study of the molecular genetics of the human auditory system into improved clinical outcomes for those with hearing loss.
Our current research includes molecular physiology of hearing loss, mouse models of hearing loss, advanced diagnostics (exome, genome, and long-read sequencing) for hearing loss, newborn genetic hearing screening, and clinical trials for gene therapy for hearing loss.
Boston Children’s Cochlear Gene Therapy Patient Featured in The Boston Globe
Story highlights clinical trial research conducted by members of the Translational Hearing Genomics Lab
